Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Takako NOMURA"'
Autor:
Tomoko Tadokoro, Joji Tani, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Koji Fujita, Takako Nomura, Asahiro Morishita, Hideki Kobara, Takashi Himoto, Masafumi Ono, Tsutomu Masaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on the efficacy of direct oral anticoagulants are increasing, and further evidence is n
Externí odkaz:
https://doaj.org/article/edf0293d1b7b41aca4d8da2b8ed176f0
Autor:
Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Tsutomu Masaki
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall prognosis of AIH is unknown, and treatment has not been established. Aim To inv
Externí odkaz:
https://doaj.org/article/b1e1db6200a24ae49e2fc299f5bec07e
Autor:
Kyoko Oura, Asahiro Morishita, Joji Tani, Takako Nomura, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Takayuki Sanomura, Yoshihiro Nishiyama, Tsutomu Masaki
Publikováno v:
Cancers, Vol 15, Iss 6, p 1834 (2023)
Sarcopenia-related factors, including the skeletal muscle index (SMI), are reportedly associated with prognosis in patients with hepatocellular carcinoma (HCC) receiving various treatments. However, there is no evidence relating to hepatic arterial i
Externí odkaz:
https://doaj.org/article/c2143691e8c540d7b0af5b28db481bd4
Autor:
Asahiro Morishita, Joji Tani, Takako Nomura, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Tingting Shi, Hiroki Yamana, Takanori Matsui, Tadayuki Takata, Takayuki Sanomura, Yoshihiro Nishiyama, Takashi Himoto, Tetsu Tomonari, Akio Moriya, Tomonori Senoo, Koichi Takaguchi, Tsutomu Masaki
Publikováno v:
Cancers, Vol 13, Iss 18, p 4605 (2021)
EB-TACE has recently been performed because of its lower hepatotoxicity compared to cTACE in less advanced HCC. However, local recurrence at the tumor margins is often observed after DEB-TACE. cTACE involves filling the intratumoral sinusoids with li
Externí odkaz:
https://doaj.org/article/a27130038f564753818eb273f6f8ea2c
Autor:
Takashi Himoto, Koji Fujita, Takako Nomura, Joji Tani, Asahiro Morishita, Hirohito Yoneyama, Reiji Haba, Tsutomu Masaki
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 9, Iss 1, Pp 1-8 (2017)
Abstract Background Ten to forty percent of nonalcoholic steatohepatitis (NASH) and HCV-related chronic liver disease (CLD-C) patients have antinuclear antibodies (ANAs). However, the relationship between autoimmune response and insulin resistance re
Externí odkaz:
https://doaj.org/article/307c7e97d8264b9ca2e715ac17279335
Autor:
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Takako Nomura, Teiji Kuzuya, Kazuhiro Kasai, Yohei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Akio Ishihara, Akihiro Deguchi, Hirotaka Arai, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Hajime Aino, Norito Matsukuma, Satoru Matsugaki, Kei Ogata, Yoichi Yano, Takato Ueno, Masahiko Kajiwara, Satoshi Itano, Kunitaka Fukuizumi, Hiroshi Kawano, Kazunori Noguchi, Masatoshi Tanaka, Taizo Yamaguchi, Ryoko Kuromatsu, Atsushi Kawaguchi, Hironori Koga, Takuji Torimura, New FP Study Group, Kurume Liver Cancer Study Group of Japan
Publikováno v:
Cancers, Vol 13, Iss 4, p 646 (2021)
BACKROUND: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with molecular targeted agents such as sorafenib. We investigated whether New-FP (fine-powder cisplatin and 5-fluorouracil), a hepatic arterial infusion chemothera
Externí odkaz:
https://doaj.org/article/71bc21f0b8c34d71a03bcf96c9bb2781
Autor:
Koji Fujita, Takako Nomura, Asahiro Morishita, Tingting Shi, Kyoko Oura, Joji Tani, Hideki Kobara, Kunihiko Tsutsui, Takashi Himoto, Tsutomu Masaki
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 8, p 1258 (2019)
Albumin−bilirubin (ALBI) grade is defined using the ALBI score, which is calculated based on total serum bilirubin and albumin. This study aimed to evaluate the diagnostic ability of the ALBI score for determining hepatic fibrosis stage and transpl
Externí odkaz:
https://doaj.org/article/8621e1643c4c4b59a14a99b2b371458d
Autor:
Koji Fujita, Noriyuki Kuroda, Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Takako Nomura, Hirohito Yoneyama, Takeshi Arai, Takashi Himoto, Seishiro Watanabe, Tsutomu Masaki
Publikováno v:
Journal of Clinical Medicine, Vol 7, Iss 9, p 267 (2018)
Background: Chronic liver diseases (CLDs) generally progress from inflammation to fibrosis and finally to carcinogenesis. Staging of liver fibrosis progression is inevitable for the management of CLD patients. The purpose of this study was to compare
Externí odkaz:
https://doaj.org/article/6e9134d271fa411fb52b0737ce269ae9
Autor:
Koji Fujita, Shima Mimura, Hisakazu Iwama, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Takako Nomura, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Makoto Oryu, Takashi Himoto, Hironori Nishitsuji, Kunitada Shimotohno, Masao Omata, Tsutomu Masaki
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 7, p 1940 (2018)
The therapeutic goal for hepatitis B virus (HBV) infection is HBs antigen (HBsAg) seroclearance, which is achieved through 48-week pegylated interferon (Peg-IFN) therapy. This study aimed to identify predictive biomarkers for sustained HBsAg reductio
Externí odkaz:
https://doaj.org/article/fcd6ecc3524d4e62a90ddb1502376e90
Autor:
Koji Fujita, Hisakazu Iwama, Kyoko Oura, Tomoko Tadokoro, Eri Samukawa, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Takashi Himoto, Mitsuomi Hirashima, Tsutomu Masaki
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 1, p 74 (2017)
Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer activities of lectin, defined as a carbohydrate-binding protein that is not an enzyme or a
Externí odkaz:
https://doaj.org/article/96d63aa9ee8f44aab3bef95210a149ef